Spreadsheet: 9162a3be-610d-4402-90c3-21bc5a94daa9
Sheet: Websheet

 |  |  |  |  |  |  |  | REPORTED SALES vs. PRIOR PERIOD ($[NAME])
 | SECOND QUARTER |  |  |  |  |  | SIX MONTHS
 |  |  | % Change |  |  |  |  |  | % Change
 | 2011 | 2010 | Reported | Operational (1) | Currency |  | 2011 | 2010 | Reported | Operational (1) | Currency
CONSUMER SEGMENT (2)
BABY CARE
US | 105 | 99 | 0.061 | 0.061 | 0 |  | 210 | 202 | 0.04 | 0.04 | 0
Intl | 493 | 438 | 0.126 | 0.05 | 0.076 |  | 949 | 864 | 0.098 | 0.041 | 0.057
WW | 598 | 537 | 0.114 | 0.052 | 0.062 |  | 1159 | 1066 | 0.087 | 0.04099999999999999 | 0.046
ORAL CARE
US | 158 | 148 | 0.068 | 0.068 | 0 |  | 321 | 322 | -0.003 | -0.003 | 0
Intl | 241 | 224 | 0.076 | -0.021 | 0.097 |  | 469 | 431 | 0.088 | 0.016 | 0.072
WW | 399 | 372 | 0.073 | 0.015 | 0.058 |  | 790 | 753 | 0.049 | 0.008000000000000007 | 0.04099999999999999
OTC/NUTRITIONALS
US | 330 | 492 | -0.329 | -0.329 | 0 |  | 727 | 1034 | -0.297 | -0.297 | 0
Intl | 753 | 649 | 0.16 | 0.04751926040061634 | 0.1124807395993837 |  | 1485 | 1314 | 0.13 | 0.0584627092846271 | 0.0715372907153729
WW | 1083 | 1141 | -0.051 | -0.115 | 0.064 |  | 2212 | 2348 | -0.058 | -0.098 | 0.04
SKIN CARE
US | 449 | 422 | 0.064 | 0.064 | 0 |  | 875 | 874 | 0.001 | 0.001 | 0
Intl | 480 | 421 | 0.14 | 0.04300000000000001 | 0.097 |  | 953 | 889 | 0.072 | 0.011 | 0.061
WW | 929 | 843 | 0.102 | 0.05299999999999999 | 0.049 |  | 1828 | 1763 | 0.037 | 0.005999999999999998 | 0.031
WOMEN'S HEALTH
US | 121 | 137 | -0.117 | -0.117 | 0 |  | 246 | 283 | -0.131 | -0.131 | 0
Intl | 356 | 329 | 0.082 | -0.008999999999999994 | 0.091 |  | 690 | 652 | 0.058 | -0.000999999999999994 | 0.059
WW | 477 | 466 | 0.024 | -0.04 | 0.064 |  | 936 | 935 | 0.001 | -0.03999999999999999 | 0.04099999999999999
WOUND CARE/OTHER
US | 176 | 165 | 0.067 | 0.067 | 0 |  | 305 | 308 | -0.01 | -0.01 | 0
Intl | 131 | 123 | 0.065 | -0.0325609756097561 | 0.0975609756097561 |  | 245 | 240 | 0.021 | -0.04566666666666666 | 0.06666666666666667
WW | 307 | 288 | 0.066 | 0.028 | 0.038 |  | 550 | 548 | 0.004 | -0.027 | 0.031
TOTAL CONSUMER
US | 1339 | 1463 | -0.085 | -0.085 | 0 |  | 2684 | 3023 | -0.112 | -0.112 | 0
Intl | 2454 | 2184 | 0.124 | 0.028 | 0.096 |  | 4791 | 4390 | 0.091 | 0.026 | 0.065
WW | 3793 | 3647 | 0.04 | -0.018 | 0.058 |  | 7475 | 7413 | 0.008 | -0.03 | 0.038
See footnotes at end of schedule
 |  |  |  |  |  |  |  | REPORTED SALES vs. PRIOR PERIOD ($[NAME])
 | SECOND QUARTER |  |  |  |  |  | SIX MONTHS
 |  |  | % Change |  |  |  |  |  | % Change
 | 2011 | 2010 | Reported | Operational (1) | Currency |  | 2011 | 2010 | Reported | Operational (1) | Currency
PHARMACEUTICAL SEGMENT  (2) (4)
ACIPHEX/PARIET
US | 101 | 121 | -0.165 | -0.165 | 0 |  | 210 | 240 | -0.125 | -0.125 | 0
Intl | 146 | 133 | 0.098 | -0.027 | 0.125 |  | 276 | 274 | 0.007 | -0.059 | 0.066
WW | 247 | 254 | -0.028 | -0.094 | 0.066 |  | 486 | 514 | -0.054 | -0.089 | 0.035
CONCERTA/METHYLPHENIDATE
US | 234 | 223 | 0.049 | 0.049 | 0 |  | 488 | 454 | 0.075 | 0.075 | 0
Intl | 115 | 100 | 0.15 | 0.03599999999999999 | 0.114 |  | 223 | 198 | 0.126 | 0.049 | 0.077
WW | 349 | 323 | 0.08 | 0.045 | 0.035 |  | 711 | 652 | 0.09 | 0.067 | 0.023
DOXIL/CAELYX
US | 56 | 78 | -0.282 | -0.282 | 0 |  | 120 | 150 | -0.2 | -0.2 | 0
Intl | 82 | 10 | * | * | 0.11 |  | 157 | 18 | * | * | 0.07
WW | 138 | 88 | 0.568 | 0.5029999999999999 | 0.065 |  | 277 | 168 | 0.649 | 0.609 | 0.04
DURAGESIC/FENTANYL TRANSDERMAL
US | 34 | 37 | -0.081 | -0.081 | 0 |  | 38 | 75 | -0.493 | -0.493 | 0
Intl | 133 | 147 | -0.095 | -0.198 | 0.103 |  | 256 | 293 | -0.126 | -0.193 | 0.067
WW | 167 | 184 | -0.092 | -0.174 | 0.08199999999999999 |  | 294 | 368 | -0.201 | -0.254 | 0.053
LEVAQUIN/FLOXIN
US | 149 | 289 | -0.484 | -0.484 | 0 |  | 571 | 652 | -0.124 | -0.124 | 0
Intl | 10 | 11 | -0.091 | -0.133 | 0.042 |  | 22 | 19 | 0.158 | 0.11 | 0.048
WW | 159 | 300 | -0.47 | -0.472 | 0.002 |  | 593 | 671 | -0.116 | -0.117 | 0.001
PREZISTA
US | 128 | 99 | 0.293 | 0.293 | 0 |  | 254 | 188 | 0.351 | 0.351 | 0
Intl | 185 | 105 | 0.762 | 0.659 | 0.103 |  | 325 | 203 | 0.601 | 0.543 | 0.058
WW | 313 | 204 | 0.534 | 0.473 | 0.061 |  | 579 | 391 | 0.481 | 0.4480000000000001 | 0.033
PROCRIT/EPREX
US | 257 | 306 | -0.16 | -0.16 | 0 |  | 447 | 596 | -0.25 | -0.25 | 0
Intl | 218 | 220 | -0.009 | -0.112 | 0.103 |  | 425 | 453 | -0.062 | -0.118 | 0.05599999999999999
WW | 475 | 526 | -0.097 | -0.14 | 0.043 |  | 872 | 1049 | -0.169 | -0.193 | 0.024
REMICADE
US | 836 | 783 | 0.068 | 0.068 | 0 |  | 1624 | 1563 | 0.039 | 0.039 | 0
US Exports (3) | 527 | 341 | 0.545 | 0.545 | 0 |  | 1017 | 741 | 0.372 | 0.372 | 0
Intl | 8 | 6 | 0.333 | 0.333 | 0 |  | 15 | 12 | 0.25 | 0.25 | 0
WW | 1371 | 1130 | 0.213 | 0.213 | 0 |  | 2656 | 2316 | 0.147 | 0.147 | 0
RISPERDAL/RISPERIDONE
US | 11 | -17 | 0 | 0 | 0 |  | 19 | -12 | 0 | 0 | 0
Intl | 128 | 134 | -0.045 | -0.141 | 0.096 |  | 247 | 267 | -0.075 | -0.144 | 0.069
WW | 139 | 117 | 0.188 | 0.078 | 0.11 |  | 266 | 255 | 0.043 | -0.03 | 0.073
RISPERDAL CONSTA
US | 110 | 115 | -0.043 | -0.043 | 0 |  | 224 | 232 | -0.034 | -0.034 | 0
Intl | 294 | 240 | 0.225 | 0.087 | 0.138 |  | 584 | 502 | 0.163 | 0.089 | 0.07400000000000001
WW | 404 | 355 | 0.138 | 0.045 | 0.09300000000000001 |  | 808 | 734 | 0.101 | 0.05000000000000001 | 0.051
TOPAMAX
US | 41 | 59 | -0.305 | -0.305 | 0 |  | 91 | 116 | -0.216 | -0.216 | 0
Intl | 80 | 83 | -0.036 | -0.132 | 0.096 |  | 159 | 174 | -0.086 | -0.138 | 0.052
WW | 121 | 142 | -0.148 | -0.204 | 0.05599999999999999 |  | 250 | 290 | -0.138 | -0.169 | 0.031
VELCADE
US | 0 | 0 | 0 | 0 | 0 |  | 0 | 0 | 0 | 0 | 0
Intl | 347 | 286 | 0.213 | 0.09999999999999999 | 0.113 |  | 627 | 547 | 0.146 | 0.07899999999999999 | 0.067
WW | 347 | 286 | 0.213 | 0.09999999999999999 | 0.113 |  | 627 | 547 | 0.146 | 0.07899999999999999 | 0.067
OTHER
US | 755 | 676 | 0.117 | 0.117 | 0 |  | 1527 | 1321 | 0.156 | 0.156 | 0
Intl | 1248 | 968 | 0.289 | 0.1762220378849606 | 0.1127779621150394 |  | 2346 | 1915 | 0.225 | 0.1515857978535793 | 0.07341420214642072
WW | 2003 | 1644 | 0.218 | 0.1515954578300741 | 0.06640454216992588 |  | 3873 | 3236 | 0.197 | 0.1541467252440063 | 0.04285327475599372
TOTAL PHARMACEUTICAL
US | 3239 | 3110 | 0.041 | 0.041 | 0 |  | 6630 | 6316 | 0.05 | 0.05 | 0
Intl | 2994 | 2443 | 0.226 | 0.107 | 0.119 |  | 5662 | 4875 | 0.161 | 0.089 | 0.07200000000000001
WW | 6233 | 5553 | 0.122 | 0.06999999999999999 | 0.052 |  | 12292 | 11191 | 0.098 | 0.067 | 0.031
See footnotes at end of schedule
 | REPORTED SALES vs. PRIOR PERIOD ($[NAME])
 | SECOND QUARTER |  |  |  |  | 0 | SIX MONTHS
 |  |  | Total |  |  |  |  |  | Total
MAJOR NEW PHARM PRODUCTS (4) | 2011 | 2010 | % Change |  |  |  | 2011 | 2010 | % Change
(INCLUDED IN OTHER)
INTELENCE
US | 38 | 32 | 0.188 |  |  |  | 76 | 63 | 0.206
Intl | 41 | 24 | 0.708 |  |  |  | 72 | 48 | 0.5
WW | 79 | 56 | 0.411 |  |  |  | 148 | 111 | 0.333
INVEGA
US | 76 | 68 | 0.118 |  |  |  | 145 | 137 | 0.058
Intl | 52 | 34 | 0.529 |  |  |  | 103 | 73 | 0.411
WW | 128 | 102 | 0.255 |  |  |  | 248 | 210 | 0.181
SIMPONI
US | 61 | 47 | 0.298 |  |  |  | 114 | 86 | 0.326
Intl | 6 | 12 | -0.5 |  |  |  | 48 | 15 | 2.2
WW | 67 | 59 | 0.136 |  |  |  | 162 | 101 | 0.604
STELARA
US | 100 | 49 | 1.041 |  |  |  | 205 | 105 | 0.952
Intl | 76 | 37 | 1.054 |  |  |  | 137 | 68 | 1.015
WW | 176 | 86 | 1.047 |  |  |  | 342 | 173 | 0.977
See footnotes at end of schedule
 |  |  |  |  |  |  |  | REPORTED SALES vs. PRIOR PERIOD ($[NAME])
 | SECOND QUARTER |  |  |  |  |  | SIX MONTHS
 |  |  | % Change |  |  |  |  |  | % Change
 | 2011 | 2010 | Reported | Operational (1) | Currency |  | 2011 | 2010 | Reported | Operational (1) | Currency
MEDICAL DEVICES AND DIAGNOSTICS   (2)
CARDIOVASCULAR CARE (5)
US | 210 | 265 | -0.208 | -0.208 | 0 |  | 452 | 516 | -0.124 | -0.124 | 0
Intl | 377 | 390 | -0.033 | -0.129 | 0.096 |  | 770 | 811 | -0.051 | -0.114 | 0.063
WW | 587 | 655 | -0.104 | -0.161 | 0.057 |  | 1222 | 1327 | -0.079 | -0.117 | 0.038
DEPUY
US | 770 | 776 | -0.008 | -0.008 | 0 |  | 1581 | 1590 | -0.006 | -0.006 | 0
Intl | 699 | 599 | 0.167 | 0.04000000000000001 | 0.127 |  | 1391 | 1239 | 0.123 | 0.042 | 0.081
WW | 1469 | 1375 | 0.068 | 0.013 | 0.055 |  | 2972 | 2829 | 0.051 | 0.01499999999999999 | 0.036
DIABETES CARE
US | 333 | 313 | 0.064 | 0.064 | 0 |  | 644 | 603 | 0.068 | 0.068 | 0
Intl | 348 | 303 | 0.149 | 0.04099999999999999 | 0.108 |  | 674 | 610 | 0.105 | 0.045 | 0.06
WW | 681 | 616 | 0.106 | 0.053 | 0.053 |  | 1318 | 1213 | 0.087 | 0.057 | 0.03
ETHICON
US | 540 | 509 | 0.061 | 0.061 | 0 |  | 1056 | 1019 | 0.036 | 0.036 | 0
Intl | 717 | 623 | 0.151 | 0.042 | 0.109 |  | 1394 | 1260 | 0.106 | 0.03699999999999999 | 0.069
WW | 1257 | 1132 | 0.11 | 0.05 | 0.06 |  | 2450 | 2279 | 0.075 | 0.037 | 0.038
ETHICON ENDO-SURGERY
US | 490 | 507 | -0.034 | -0.034 | 0 |  | 961 | 990 | -0.029 | -0.029 | 0
Intl | 805 | 689 | 0.168 | 0.05500000000000001 | 0.113 |  | 1555 | 1374 | 0.132 | 0.05800000000000001 | 0.074
WW | 1295 | 1196 | 0.083 | 0.018 | 0.065 |  | 2516 | 2364 | 0.064 | 0.021 | 0.043
ORTHO-CLINICAL DIAGNOSTICS
US | 281 | 264 | 0.064 | 0.064 | 0 |  | 546 | 552 | -0.011 | -0.011 | 0
Intl | 269 | 230 | 0.17 | 0.06400000000000002 | 0.106 |  | 525 | 467 | 0.124 | 0.052 | 0.072
WW | 550 | 494 | 0.113 | 0.064 | 0.049 |  | 1071 | 1019 | 0.051 | 0.018 | 0.033
VISION CARE
US | 245 | 232 | 0.056 | 0.056 | 0 |  | 501 | 481 | 0.042 | 0.042 | 0
Intl | 487 | 430 | 0.133 | 0.021 | 0.112 |  | 953 | 845 | 0.128 | 0.04000000000000001 | 0.088
WW | 732 | 662 | 0.106 | 0.033 | 0.073 |  | 1454 | 1326 | 0.097 | 0.04100000000000001 | 0.05599999999999999
TOTAL MEDICAL DEVICES AND DIAGNOSTICS
US | 2869 | 2865 | 0.001 | 0.001 | 0 |  | 5741 | 5751 | -0.002 | -0.002 | 0
Intl | 3702 | 3265 | 0.134 | 0.02200000000000001 | 0.112 |  | 7262 | 6606 | 0.099 | 0.02500000000000001 | 0.074
WW | 6571 | 6130 | 0.072 | 0.01299999999999999 | 0.059 |  | 13003 | 12357 | 0.052 | 0.013 | 0.039
* Percentage greater than 100%
(1) Operational growth excludes the effect of currency
(2) Select areas (unaudited)
(3) Reported in U.S. sales
(4) Prior year amounts have been reclassified to conform to current year product disclosure
(5) Previously Cordis